relative to insurance coverage for glucose monitoring.

Summary

The bill amends New Hampshire insurance statutes so that coverage for blood glucose monitors and continuous glucose monitoring systems (CGMS) cannot be conditioned on a patient’s insulin regimen, testing frequency, or other treatment forms. Insurers must include at least two models of each device type in their preferred provider lists, and a prescription or referral from an endocrinologist is required along with prior authorization. This expands access for people with diabetes who may not use insulin but still need monitoring tools.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share